WhaleWatch
Sign inGet started
Smart Money Alert
Alkem Laboratories Limited logo

Alkem Laboratories Limited

New PositionBlock Deal
ALKEMPharmaceuticalsMarket Cap₹63K Cr
Value
₹25.01 Cr
Shares
48,090
Price
₹5,200
Societe Generale
Societe Generale
Foreign Investor
The move

Societe Generale bought 48,090 shares of Alkem Laboratories for ₹25.01 Cr at ₹5200.00 apiece in a block deal.

About Alkem Laboratories Limited
Visit stock

A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.

About Societe Generale
Visit investor

French global investment bank with around EUR 1.6 trillion in assets. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.

Get the next move the moment it happens.
Follow Societe Generale and Alkem Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Alkem Laboratories Limited shareholdersSociete Generale's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Alkem Laboratories Limited
More moves in Alkem Laboratories Limited
HDFC Mutual FundIncreased
HDFC Mutual Fund bought 25,019 shares of Alkem Laboratories in the open market. This purchase raised its stake from 5.00% to 5.02%, crossing the 5% disclosure threshold.
24 Aug 2026
Read more
LICDecreased
LIC decreased its stake in Alkem Laboratories by selling 147,955 shares, reducing its holding from 1.56% to 1.43%. The value of the shares sold is ₹82.26 crore at ₹5563.00 apiece.
19 Jul 2026
Read more
SBI Mutual FundDecreased
SBI Mutual Fund decreased its stake in Alkem Laboratories from 2.42% to 1.99%, selling 508,608 shares for ₹283.05 crore at ₹5563.00 apiece.
19 Jul 2026
Read more
HDFC Life InsuranceDecreased
HDFC Life Insurance decreased its stake in Alkem Laboratories from 1.33% to 1.31%, selling 34,427 shares.
9 Jul 2026
Read more
DSP Mutual FundIncreased
DSP Mutual Fund increased its stake in Alkem Laboratories from 1.45% to 1.78% by purchasing 398,949 shares for ₹223.61 crore at ₹5606.00 apiece.
9 Jul 2026
Read more
See all moves
Societe Generale
More moves by Societe Generale
Capri Global Capital Limited
Direction, size, price and stake change for this move, with what it means for the company.
1 Oct 2026. Sign in to see this move
SEDEMAC Mechatronics LimitedNew position
Societe Generale bought 1,61,967 shares of SEDEMAC Mechatronics Limited for ₹48.75 Cr at ₹3010.00 apiece in a block deal.
SEDEMAC24 Sept 2026
Read more
Meesho LimitedNew position
Societe Generale bought 35.5 lakh shares of Meesho Limited for ₹82.72 Cr at ₹233 apiece in a block deal.
MEESHO23 Sept 2026
Read more
Pine Labs LimitedNew position
Societe Generale bought 87.7 lakh shares of Pine Labs Limited for ₹164.66 Cr at ₹187.75 apiece in a block deal.
PINELABS22 Sept 2026
Read more
Computer Age Management Services LimitedNew position
Societe Generale bought 37.12 lakh shares of Computer Age Management Services Limited for ₹253.06 Cr at ₹681.75 apiece in a bulk deal.
CAMS10 Sept 2026
Read more
See all moves